Comparison of 1-year therapeutic effect of ranibizumab and bevacizumab for myopic choroidal neovascularization: a retrospective, multicenter, comparative study

Overview of attention for article published in BMC Ophthalmology, May 2014

Altmetric Badge

About this Attention Score

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 1,933 followers.

Comparison of 1-year therapeutic effect of ranibizumab and bevacizumab for myopic choroidal neovascularization: a … http://t.co/pLRm1CTuEg

Comparison of 1-year therapeutic effect of ranibizumab and bevacizumab for myopic choroidal neovascularization: ... http://t.co/HfxVkRJj7U

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.